chr19-40282734-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001626.6(AKT2):c.-85+2447A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.737 in 333,054 control chromosomes in the GnomAD database, including 91,528 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.76 ( 44631 hom., cov: 32)
Exomes 𝑓: 0.72 ( 46897 hom. )
Consequence
AKT2
NM_001626.6 intron
NM_001626.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.495
Publications
19 publications found
Genes affected
AKT2 (HGNC:392): (AKT serine/threonine kinase 2) This gene is a putative oncogene encoding a protein belonging to a subfamily of serine/threonine kinases containing SH2-like (Src homology 2-like) domains, which is involved in signaling pathways. The gene serves as an oncogene in the tumorigenesis of cancer cells For example, its overexpression contributes to the malignant phenotype of a subset of human ductal pancreatic cancers. The encoded protein is a general protein kinase capable of phophorylating several known proteins, and has also been implicated in insulin signaling. [provided by RefSeq, Nov 2019]
MIR641 (HGNC:32897): (microRNA 641) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.899 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.760 AC: 115502AN: 151982Hom.: 44592 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
115502
AN:
151982
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.717 AC: 129811AN: 180952Hom.: 46897 Cov.: 0 AF XY: 0.724 AC XY: 72238AN XY: 99836 show subpopulations
GnomAD4 exome
AF:
AC:
129811
AN:
180952
Hom.:
Cov.:
0
AF XY:
AC XY:
72238
AN XY:
99836
show subpopulations
African (AFR)
AF:
AC:
2983
AN:
3344
American (AMR)
AF:
AC:
5666
AN:
7496
Ashkenazi Jewish (ASJ)
AF:
AC:
2357
AN:
3664
East Asian (EAS)
AF:
AC:
2982
AN:
4544
South Asian (SAS)
AF:
AC:
30367
AN:
39784
European-Finnish (FIN)
AF:
AC:
11000
AN:
16348
Middle Eastern (MID)
AF:
AC:
724
AN:
1006
European-Non Finnish (NFE)
AF:
AC:
67770
AN:
96434
Other (OTH)
AF:
AC:
5962
AN:
8332
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1709
3418
5126
6835
8544
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
356
712
1068
1424
1780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.760 AC: 115603AN: 152102Hom.: 44631 Cov.: 32 AF XY: 0.757 AC XY: 56254AN XY: 74340 show subpopulations
GnomAD4 genome
AF:
AC:
115603
AN:
152102
Hom.:
Cov.:
32
AF XY:
AC XY:
56254
AN XY:
74340
show subpopulations
African (AFR)
AF:
AC:
37617
AN:
41498
American (AMR)
AF:
AC:
11583
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
AC:
2232
AN:
3472
East Asian (EAS)
AF:
AC:
3457
AN:
5158
South Asian (SAS)
AF:
AC:
3709
AN:
4826
European-Finnish (FIN)
AF:
AC:
6928
AN:
10578
Middle Eastern (MID)
AF:
AC:
205
AN:
294
European-Non Finnish (NFE)
AF:
AC:
47649
AN:
67982
Other (OTH)
AF:
AC:
1557
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1370
2739
4109
5478
6848
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
850
1700
2550
3400
4250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2584
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.